G A Meijer

Author PubWeight™ 98.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007 3.53
2 Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 2005 2.70
3 Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006 2.56
4 Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006 2.02
5 Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012 1.98
6 MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009 1.87
7 Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2008 1.77
8 High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides. J Clin Pathol 2004 1.71
9 Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002 1.65
10 Surveillance in Barrett's oesophagus: a critical reappraisal. Scand J Gastroenterol Suppl 2002 1.63
11 Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet 2004 1.61
12 Comparative genomic hybridisation. Mol Pathol 1999 1.56
13 There is no increased risk for colorectal cancer and adenomas in patients with diverticulitis: a retrospective longitudinal study. Colorectal Dis 2010 1.53
14 Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol 2001 1.50
15 Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007 1.47
16 Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol 2011 1.36
17 Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects. J Pathol 1999 1.32
18 Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 2006 1.32
19 Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 1998 1.29
20 Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 1999 1.28
21 Long-term effect of physical activity on energy balance and body composition. Br J Nutr 1992 1.26
22 Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group. J Clin Pathol 2003 1.18
23 Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors. Oncogene 2006 1.15
24 Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol 2010 1.15
25 Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 2012 1.15
26 Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 2007 1.14
27 Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur J Cancer 2011 1.14
28 Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test. Aliment Pharmacol Ther 2009 1.10
29 Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 1998 1.09
30 Microarray techniques in pathology: tool or toy? Mol Pathol 2000 1.09
31 DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann Oncol 2009 1.07
32 Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2012 1.06
33 Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol 1996 1.05
34 A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes. Cell Oncol 2009 1.05
35 KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study. Br J Cancer 2013 1.03
36 DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell Oncol 2005 1.03
37 The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. Ann Oncol 2012 1.01
38 MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer 2008 1.00
39 High lymph node yield is related to microsatellite instability in colon cancer. Ann Surg Oncol 2011 1.00
40 Non-random allelic losses at 3p, 11p and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes. Int J Cancer 1998 1.00
41 Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma. J Clin Pathol 1996 0.99
42 Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Cell Oncol 2007 0.99
43 Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. Am J Pathol 1998 0.97
44 Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007 0.97
45 Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008 0.96
46 Syntactic structure analysis. Pathologica 1995 0.95
47 Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol 2000 0.95
48 pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited. Int J Cancer 2014 0.94
49 Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus. Anal Quant Cytol Histol 1997 0.94
50 Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors. J Pathol 1998 0.94
51 Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 2005 0.94
52 A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Ann Oncol 2013 0.93
53 Deletion of chromosome 4q predicts outcome in stage II colon cancer patients. Cell Oncol (Dordr) 2011 0.92
54 Deletion of chromosome 4q predicts outcome in stage II colon cancer patients. Anal Cell Pathol (Amst) 2010 0.91
55 Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br J Cancer 2013 0.91
56 Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 2001 0.91
57 Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies. J Clin Pathol 2002 0.90
58 Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer. Anal Cell Pathol 2000 0.90
59 Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients. Br J Cancer 2008 0.90
60 KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance. Virchows Arch 2012 0.88
61 New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration. J Cancer Res Clin Oncol 2007 0.88
62 Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas. Br J Haematol 2006 0.87
63 Increased apoptosis in gastric mucosa adjacent to intestinal metaplasia. J Clin Pathol 2003 0.87
64 Helicobacter pylori gastritis in Africa. Eur J Gastroenterol Hepatol 2000 0.86
65 Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012 0.85
66 Rapid and reliable assessment of volume percentage of epithelium in borderline and invasive ovarian tumors. Anal Quant Cytol Histol 1998 0.84
67 Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT. Cell Oncol 2005 0.84
68 Comparative genomic hybridisation as a supportive tool in diagnostic pathology. J Clin Pathol 2003 0.84
69 Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice. Cancer Sci 2008 0.83
70 Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. Ann Oncol 2011 0.83
71 Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Lab Invest 2001 0.83
72 Fat-free mass as a function of fat mass and habitual activity level. Int J Sports Med 1992 0.82
73 Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. Gynecol Oncol 1998 0.82
74 Biomechanical vibration of the abdominal region during running and bicycling. J Sports Med Phys Fitness 1991 0.82
75 Experience with a dynamic inexpensive video-conferencing system for frozen section telepathology. Anal Cell Pathol 2000 0.82
76 Hepatic fatty acid composition in periparturient dairy cows with fatty liver induced by intake of a high energy diet in the dry period. J Dairy Sci 1999 0.81
77 Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization. Histopathology 2007 0.81
78 Body mass, body composition and sleeping metabolic rate before, during and after endurance training. Eur J Appl Physiol Occup Physiol 1994 0.81
79 Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer. Br J Cancer 2013 0.80
80 Testing the value of a measurement protocol for DNA image cytometry and comparing different cytologic preparations. Anal Quant Cytol Histol 1996 0.79
81 Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol 2003 0.79
82 Further testing of the value of a measurement protocol for DNA ploidy studies using image cytometry. Comparison of results obtained from cytologic and paraffin section preparations. Anal Quant Cytol Histol 1996 0.79
83 Rapid stereology based quantitative immunohistochemistry of dendritic cells in lymph nodes: a methodological study. Anal Cell Pathol 2001 0.79
84 An evaluation of prognostic factors in advanced ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1995 0.79
85 Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study. Am J Gastroenterol 2001 0.78
86 DNA ploidy and nuclear morphometry for the classification of dysplastic nevi. Anal Quant Cytol Histol 1999 0.77
87 Peri-operative bowel perforation in early stage colon cancer is associated with an adverse oncological outcome. J Gastrointest Surg 2012 0.77
88 p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis. J Pathol 1999 0.77
89 Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. Br J Cancer 2009 0.77
90 Physical activity and sleeping metabolic rate. Med Sci Sports Exerc 1991 0.75
91 Targeted therapies; who detects the target? Cell Oncol 2005 0.75
92 Detection of chromosomal abnormalities by comparative genomic hybridization. Methods Mol Biol 2001 0.75
93 Volume-weighted mean nuclear volume and nuclear area in advanced ovarian carcinoma. An investigation of sampling methods, sample size and reproducibility. Anal Quant Cytol Histol 1995 0.75
94 Exploring the possibility of DNA ploidy measurements in tissue sections using liver as a model. Anal Quant Cytol Histol 1997 0.75
95 Influence of section thickness, mean nuclear diameter and nuclear crowding on DNA ploidy in histologic sections of melanocytic skin lesions. Anal Quant Cytol Histol 1999 0.75
96 Cytogenetic characteristics of oral squamous cell carcinomas in Fanconi anemia. Fam Cancer 2001 0.75
97 [Drug residues: consequences for stock owners]. Tijdschr Diergeneeskd 1984 0.75
98 Reporting by digital speech recognition. Hum Pathol 1995 0.75
99 [Integrated monitoring of the meat production chain and the interest of the stock-farmer]. Tijdschr Diergeneeskd 1984 0.75
100 [Oncogenes, tumor suppressor genes and the medical genetics of cancer]. Ned Tijdschr Geneeskd 1992 0.75
101 [Current surveillance policy for Barrett's oesophagus in the Netherlands]. Ned Tijdschr Geneeskd 2007 0.75
102 CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 2017 0.75
103 Patient reports. Anaesth Intensive Care 1989 0.75
104 Minimum spanning tree analysis in advanced ovarian carcinoma. An investigation of sampling methods, reproducibility and correlation with histologic grade. Anal Quant Cytol Histol 1997 0.75